Dr. Brufsky Discusses Future Research Into Bisphosphonates

Dr. Brufsky Discusses Future Research into Bisphosphonates

Dr. Brufsky Discusses Adjuvant Bisphosphonates as a New Standard of Care

Targeted Oncology

Dr. Brufsky on Adjuvant Bisphosphonates for Patients with Breast Cancer

Dr. Gralow on Future Research Into Bisphosphonates in Breast Cancer

Targeted Oncology

Bisphosphonate Use in Breast Cancer

Bisphosphonates and Cancer

Margaret Martin, Physical Therapist

Dr. Brufsky on Trastuzumab and Eribulin for HER2+ Metastatic Breast Cancer

ASCO Update: Bisphosphonate Effect in Breast Cancer

Professor Ingunn Holen and research into bisphosphonates for breast cancer

Breast Cancer Now

NEW OSTEOPOROSIS TECHNOLOGY: Understanding Your REMS Report for Future Stronger Bones

Dr. Susan E. Brown

Taking Fosamax? This bone drug linked to osteoporosis may be linked to the problem!

Dr. Susan E. Brown

Adam Brufsky, MD, PhD: Expectations of Therapy

Targeted Oncology

Dr. Brufsky Advises Doctors on Bevacizumab for Breast Cancer

Osteoporosis – Are bisphosphonates worth it?

Dr. Ford Brewer

Bisphosphonates and Atherosclerosis

MDedge: news and insights for busy physicians

Adam Brufsky, MD - University of Pittsburgh Medical Center

Professor Rob Coleman explains landmark bisphosphonates results

Breast Cancer Now

Worst Drug for Osteoporosis Reels

The Dr Doug Show | Bones, Hormones and HealthSpan

Worst Drug for Osteoporosis Reels

The Dr Doug Show | Bones, Hormones and HealthSpan

Are bisphosphonates an effective treatment for early stage breast cancer?